Clinical Trial

The Low FODMAP Diet in Individuals With Small Intestinal Bacterial Overgrowth (SIBO)

Completed
View on ClinicalTrials.gov →
Summary
This study aims to assess the impact of a low FODMAP diet (LFD) on gastrointestinal symptoms and nutritional status in individuals diagnosed with small intestinal bacterial overgrowth (SIBO). Participants were randomly assigned to either an intervention group or a control group following completion of antibiotic therapy. The intervention group followed a LFD, while the control group followed a normal diet, in accordance with the principles of rational nutrition. Gastrointestinal symptoms, nutritional status, and quality of life were assessed using questionnaires, dietary records, anthropometric measurements, and blood biochemical parameters.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2026-02-13.
Trial Details
NCT Number NCT07424313
Lead Sponsor Warsaw University of Life Sciences
Conditions SIBO, Small Intestinal Bacterial Overgrowth, Small Intestinal Bacterial Overgrowth Syndrome (SIBO)
Enrollment 51 participants
Start Date 2024-02-08
Primary Completion 2025-09-18 (estimated)
Study Completion 2026-01-15 (estimated)
Updated on ClinicalTrials.gov 2026-02-24